Lovastatin D3
| Product Name | Lovastatin D3 |
|---|---|
| Alternate Names | Lovastatin Stable Isotopes, Stable Isotopes of Lovastatin |
| CAT No. | CS-O-06735 |
| CAS No. | 1002345-93-8 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 407.56 g/mol |
| Mol. For. | C₂₄H₃₃D₃O₅ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Lovastatin |
| Purity | 95% |
| Therapeutic | Anti-Diabetic |
| Smileys | O=C([C@@H](C([2H])([2H])[2H])CC)O[C@@H]1[C@@]([C@H]2CC[C@@H](OC3=O)C[C@H](C3)O)([H])C(C=C[C@@H]2C)=C[C@H](C)C1 |
| Canonical Smiles | CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C |
| InchIKey | PCZOHLXUXFIOCF-VWOIVJJTSA-N |
| Inchl | InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15+,16-,18+,19+,20-,21-,23-/m0/s1/i3D3 |
| IUPAC | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2R)-2-(trideuteriomethyl)butanoate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Lovastatin D3 is a cholesterol-lowering medication that is used to treat high cholesterol levels in the blood. Lovastatin D3 belongs to a group of medications known as statins, which work by blocking the production of cholesterol in the liver. Lovastatin D3 is also known as Mevacor and is available in tablet form.
Lovastatin D3 is a deuterated form of lovastatin, which means it contains three hydrogen atoms that have been replaced with deuterium atoms. Deuterated compounds have been shown to have different pharmacological properties than their non-deuterated counterparts. Lovastatin D3 has been used in pharmacokinetic studies to evaluate the metabolism and elimination of lovastatin in the body.
Lovastatin D3 is metabolized in the liver by the cytochrome P450 enzyme system. The primary metabolite of lovastatin D3 is lovastatin acid, which has similar pharmacological properties to lovastatin. Lovastatin D3 has a half-life of approximately three hours and is excreted in the urine and feces.
Lovastatin D3 is typically prescribed to patients with high cholesterol levels who have not responded to non-pharmacological interventions such as diet and exercise. It is also used in patients with a history of heart disease to prevent future cardiovascular events. Lovastatin D3 is generally well-tolerated, but like all medications, it may cause side effects. Common side effects include muscle pain and weakness, headache, and gastrointestinal disturbances.
Get an Instant Quote
Related Compounds
Lovastatin-d9 | Epi Lovastatin-d3 | Epi Lovastatin Hydroxy Acid-d3 Sodium Salt | Lovastatin Hydroxy D3 ammonium salt |